Linda Stocum, Associate Editor

ICYMI, some of this week’s featured content includes an exclusive interview about hyperhidrosis, and articles on a new the ACAAI annual scientific meeting this weekend, clascoterone cream, and more.

Several doctors were recognized at the American College of Allergy, Asthma, & Immunology annual scientific meeting held November 4 to 8 in New Orleans, Louisiana.

Incyte announced that ruxolitinib cream has received validation for its European marketing authorization application from the European Medicines Agency.

In this episode, we dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource.

In this video, Ama Alexis, MD, tells us what we have to look forward to at the ACAAI conference this week.

Jonathan M. Spergel, MD, PhD, FACAAI discusses what there is to look forward to at the ACAAI conference and what he's highlighting at the event.

We sit down in a video interview with David Pariser, MD, FACP, FAAD, the secretary and founding member of the International Hyperhidrosis Society to discuss hyperhidrosis identifiers and treatments in honor of Hyperhidrosis Awareness Month.

In this episode of DermView, Adelaide Hebert, MD, highlights both emollients and moisturizers. She also talks about bathing and how often a child should bathe if they have eczema.

This week’s edition of The Mainstream Patient features stories about back acne, things to avoid while scars are healing and more!

Sun Pharma has announced that their Winlevi 1% cream is now available in the US to treat acne vulgaris in patients 12 years and older.

ICYMI, some of this week’s featured content includes an exclusive interview the NFCMMD symposium, and articles on ruxolitinib, what to watch in the psoriasis pipeline, and more.

Literature update highlights the treatment methods, clinical pearls, and enhancement of outcomes for the disease

The National Institute for Health and Care Excellence and the Public Health England have issued guidance on impetigo.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of October.

In this video, we talk to Michael Gold, MD, about the 11th annual New Frontiers in Cosmetic Medicine and Medical Dermatology symposium. He tells us the highlights of the conference and what makes it stands out from the rest.

This week’s edition of The Mainstream Patient features stories about psoriasis complications, what milia is and more!

In this episode of DermView, Adelaide Hebert, MD, explains the clinical manifestations of eczema, how the chronic the condition is, and the benefits of using ceramide cream for management.

Botulinum type A injections are widely used across the dermatology and aesthetic medicine specialties. At the Fall Clinical Dermatology Conference 2021, Mark S Nestor, MD, PhD, highlights how to optimize the neurotoxin to improve patient care.

People are born with sterile skin and then gain microbiota throughout their life. Lawrence J. Green, MD, FAAD, explains how this affects the skin barrier and ultimately plays a role in atopic dermatitis at the 2021 Fall Clinical Dermatology Conference.

ICYMI, some of this week’s featured content includes an exclusive interview about eczema, and articles on a new tralokinumab data, apremilast as a combination treatment, and more.

Lawrence Eichenfield, MD, provides the newest updates in pediatric patient care, with a special update on COVID-19 skin symptoms in children.

LEO Pharma releases the 16-week data regarding tralokinumab (Adtralza; LEO Pharma) as a treatment for adolescent patients aged 12 to 17 years.

How can GEP be applied to melanoma diagnosis and treatment? Darrel Rigel, MD, MS, answers these questions and dives into the data at Fall Clinical Dermatology Conference 2021.

This episode of The Cutaneous Connection podcast, Gary Linkov, MD, dives into the topic of hair loss.

On September 30, 2021, Galderma celebrated its 25th anniversary of its Restylane line of hyaluronic acid fillers.

In this episode of DermView, Adelaide Hebert, MD, explains how eczema can lead to growth issues in pediatric patients, how environmental factors may play a role in flare ups, and more.

Potenza, Cynosure’s RF microneedling system, has been cleared by Health Canada.

This week’s edition of The Mainstream Patient features stories about how biologic treatments changed 6 psoriasis patients lives, updated sunscreen regulations, and more!

Proscia announces new study data on artificial intelligence’s ability to detect melanoma.

A review of apremilast combination therapies was recently published in the Journal of Drugs in Dermatology, examining treatment efficacy and safety.